Please assess the completion status of the following clinical trial:

Trial Title: DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients 18 years and older with the diagnosis of disseminated superficial actinic porokeratosis.~Exclusion Criteria:~* Patients with allergies or contraindications to lovastatin or cholesterol~* Female patients currently pregnant or lactating.~* Female patients with plans to become pregnant.~* Patients actively taking approved forms of long-term contraception (oral contraceptives, implantable intrauterine devices, or other hormone eluting implants) will be allowed to participate as long as they have no plan to become pregnant during the course of the study. A urine pregnancy test will be administered to these patients to confirm that they can be included in the study.~* Inability or unwillingness of subject or legal guardian/representative to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Statin/Cholesterol Combination Group (Type: EXPERIMENTAL): This arm will utilize 2% cholesterol and 2% lovastatin ointment. It will be compounded by a pharmacist. Ointment will be applied on lesional skin with occlusion twice daily for 12 weeks.
- Statin Alone Group (Type: EXPERIMENTAL): This arm will utilize 2% lovastatin ointment. It will be compounded by a pharmacist. Ointment will be applied on lesional skin with occlusion twice daily for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).